drugset / Trial / NCT00230490

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

NCT00230490 ↗

Phase 2 Terminated 150 enrolled Bausch Health Americas, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Compare the long-term safety of pradefovir to adefovir dipivoxyl

Timeline

Start
2005-06
Primary completion
—
Completion
2007-05

Outcome

Outcome not reported

Stopped: “Adverse findings from nonclinical carcinogenicity studies.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir Unknown — —
Subject pradefovir Small molecule — —